Skip to main content
. Author manuscript; available in PMC: 2017 Jan 1.
Published in final edited form as: Obstet Gynecol. 2016 Jan;127(1):101–108. doi: 10.1097/AOG.0000000000001181

Table 1.

Clinical and demographic characteristics of the cohort stratified by performance of oophorectomy

Ovarian Conservation Oophorectomy

N (%) N (%) P-value Multivariable Risk Ratio (95% CI)
1121 (7.2) 14,527 (92.8)
Year of diagnosis 0.91
 1998 31 (6.9) 417 (93.1) Referent
 1999 36 (7.5) 443 (92.5) 1.08 (0.67–1.75)
 2000 49 (7.8) 581 (92.2) 1.12 (0.71–1.76)
 2001 54 (6.2) 818 (93.8) 0.94 (0.60–1.46)
 2002 76 (8.5) 823 (91.6) 1.21 (0.80–1.85)
 2003 68 (6.6) 967 (93.4) 0.98 (0.64–1.50)
 2004 71 (6.6) 1,003 (93.4) 0.98 (0.64–1.50)
 2005 88 (7.6) 1,065 (92.4) 1.14 (0.76–1.73)
 2006 90 (7.2) 1,167 (92.8) 1.08 (0.72–1.64)
 2007 94 (7.5) 1,163 (92.5) 1.13 (0.75–1.70)
 2008 87 (6.7) 1,219 (93.3) 1.01 (0.67–1.53)
 2009 98 (7.3) 1,245 (92.7) 1.11 (0.74–1.67)
 2010 100 (7.5) 1,238 (92.5) 1.14 (0.76–1.71)
 2011 90 (6.9) 1,215 (93.1) 1.05 (0.69–1.59)
 2012 89 (7.1) 1,163 (92.9) 1.07 (0.71–1.62)
Age (years) <0.0001
 45–49 357 (4.7) 7,191 (95.3) Referent
 40–44 314 (7.4) 3,941 (92.6) 1.52 (1.30–1.77)**
 35–39 241 (10.4) 2,070 (89.6) 2.19 (1.85–2.58)**
 30–34 134 (12.1) 972 (87.9) 2.54 (2.07–3.10)**
 <30 75 (17.5) 353 (82.5) 3.64 (2.82–4.69)**
Race 0.001
 White 914 (6.9) 12,312 (93.1) Referent
 Black 112 (10.0) 1,013 (90.0) 1.36 (1.11–1.67)*
 Other/unknown 95 (7.3) 1,202 (92.7) 1.01 (0.81–1.26)
Insurance status 0.85
 Commercial 870 (7.2) 11,302 (92.9) Referent
 Medicare 53 (6.8) 727 (93.2) 0.95 (0.72–1.26)
 Medicaid 89 (7.2) 1,150 (92.8) 0.89 (0.71–1.12)
 Uninsured 69 (7.0) 920 (93.0) 0.87 (0.68–1.13)
 Other 12 (7.5) 148 (92.5) 0.98 (0.55–1.76)
 Unknown 28 (9.1) 280 (90.9) 1.23 (0.83–1.81)
Comorbidity 0.001
 0 729 (7.6) 8,892 (92.4) --
 1 129 (5.6) 2,179 (94.4) --
 ≥2 17 (4.4) 374 (95.7) --
 Unknown 246 (7.4) 3,082 (92.6) --
Region 0.0003
 New England 90 (9.1) 895 (90.9) Referent
 Middle Atlantic 133 (5.8) 2,170 (94.2) 0.65 (0.48–0.88)*
 South Atlantic 234 (7.8) 2,763 (92.2) 0.77 (0.59–1.02)
 East North Central 205 (6.3) 3,040 (93.7) 0.66 (0.50–0.87)*
 East South Central 67 (6.7) 931 (93.3) 0.71 (0.50–1.02)
 West North Central 68 (5.9) 1,090 (94.1) 0.64 (0.45–0.91)
 West South Central 102 (8.0) 1,181 (92.1) 0.80 (0.58–1.10)
 Mountain 70 (9.4) 679 (90.7) 1.02 (0.72–1.45)
 Pacific 152 (7.9) 1,778 (92.1) 0.79 (0.59–1.06)
Metropolitan location 0.14
 Metropolitan 914 (7.3) 11,556 (92.7) Referent
 Urban 148 (6.4) 2,184 (93.7) 0.89 (0.74–1.06)
 Rural 12 (4.8) 238 (95.2) 0.68 (0.38–1.22)
 Unknown 47 (7.9) 549 (92.1) 0.97 (0.72–1.32)
Hospital type <0.0001
 Academic 442 (6.3) 6,556 (93.7) Referent
 Comprehensive community cancer program 563 (7.4) 7,025 (92.6) 1.74 (1.40–2.17)**
 Community cancer program 114 (11.2) 908 (88.9) 1.19 (1.03–1.37)*
 Other1 - - - -
Grade <0.0001
 1 790 (8.4) 8,627 (91.6) Referent
 2 205 (4.9) 3,955 (95.1) 0.61 (0.52–0.71)**
 3 52 (5.2) 940 (94.8) 0.70 (0.53–0.93)*
 Unknown 74 (6.9) 1,005 (93.1) 0.85 (0.67–1.08)
Stage 0.001
 IA 997 (7.2) 12945 (92.8) Referent
 IB 67 (5.7) 1105 (94.3) 0.76 (0.58–0.99)*
 INOS 57 (10.7) 477 (89.3) 0.65 (0.45–0.93)*

Due to co-linearity, we were not able to fit comorbidity and year of diagnosis in the same model.

1

Data suppressed due to small sample size within the categories.

*

P<0.05

**

P<0.0001